How about listing some companies that pay a comparable yield with franking credits. Now they would be attractive. Especially if that yield is not the result a recent large price decline.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling